The stock of Immunocore Holdings plc ADR (IMCR) is currently priced at $36.05. In the last session, the stock climbed significantly, topping out at $100.0 after opening at $36.05. The day’s lowest price was $24.71 before the stock closed at $37.15.
Immunocore Holdings plc ADR’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $40.88 on 07/26/24 and a low of $23.15 for the same time frame on 04/09/25.
52-week price history of IMCR Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Immunocore Holdings plc ADR’s current trading price is -11.82% away from its 52-week high, while its distance from the 52-week low is 55.72%. The stock’s price range during the 52-week period has remained between $23.15 and $40.88. In the Healthcare sector, the company’s shares saw a trading volume of around 0.53 million for the day, which was evidently higher than the average daily volume of 0.38 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Immunocore Holdings plc ADR (IMCR) has experienced a quarterly rise of 22.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.81B and boasts a workforce of 493 employees.
A Closer Look at Analysts’ Ratings for Immunocore Holdings plc ADR
As of right now, 9 analysts are rating Immunocore Holdings plc ADR as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 31.31, with a change in price of +6.47. Similarly, Immunocore Holdings plc ADR recorded 383,194 in trading volume during the last 100 days, posting a change of +21.87%.
Examining IMCR’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for IMCR stands at 1.15. Similarly, the long-term debt-to-equity ratio is also 1.14.
IMCR Stock Stochastic Average
As of today, Immunocore Holdings plc ADR’s raw stochastic average for the last 50 days stands at 72.42%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 77.06%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 88.02% and 91.32%, respectively.
IMCR Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -9.38% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 20.17%. Over the past 30 days, the price of IMCR has fallen by 15.84%. And in the last five days, it has surged by 0.85%.
